Thomas J. Mitchell

42.6k total citations · 3 hit papers
92 papers, 2.7k citations indexed

About

Thomas J. Mitchell is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Computer Vision and Pattern Recognition. According to data from OpenAlex, Thomas J. Mitchell has authored 92 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 22 papers in Pulmonary and Respiratory Medicine and 14 papers in Computer Vision and Pattern Recognition. Recurrent topics in Thomas J. Mitchell's work include Music Technology and Sound Studies (13 papers), Renal cell carcinoma treatment (12 papers) and Cancer Genomics and Diagnostics (12 papers). Thomas J. Mitchell is often cited by papers focused on Music Technology and Sound Studies (13 papers), Renal cell carcinoma treatment (12 papers) and Cancer Genomics and Diagnostics (12 papers). Thomas J. Mitchell collaborates with scholars based in United Kingdom, United States and Australia. Thomas J. Mitchell's co-authors include M. A. F. Kendall, P. Wrighton-Smith, Joanne Edwards, Valerie G. Brunton, David E. Neal, David Pellman, Anna Cheng, Kim Judge, John Beardall and Peter J. Campbell and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Thomas J. Mitchell

88 papers receiving 2.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Intra-tumour diversification in colorectal cancer at the single-cell level

2018 376 citations Sam Behjati, Thomas J. Mitchell et al. Nature profile →
Epidemiology of Renal Cell Carcinoma: 2022 Update

2022 358 citations Thomas J. Mitchell et al. European Urology profile →
Mechanisms generating cancer genome complexity from a single cell division error

2020 276 citations Neil T. Umbreit, Cheng‐Zhong Zhang et al. Science profile →

Peers

Countries citing papers authored by Thomas J. Mitchell

Since Specialization

Citations

This map shows the geographic impact of Thomas J. Mitchell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas J. Mitchell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas J. Mitchell more than expected).

Fields of papers citing papers by Thomas J. Mitchell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas J. Mitchell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas J. Mitchell. The network helps show where Thomas J. Mitchell may publish in the future.

Co-authorship network of co-authors of Thomas J. Mitchell

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas J. Mitchell. A scholar is included among the top collaborators of Thomas J. Mitchell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas J. Mitchell. Thomas J. Mitchell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Evidence of DNA methylation heterogeneity and epipolymorphism in kidney cancer tissue samples 2025 ·Oncogene ·Sabrina H. Rossi, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Gahee Park, Christopher G. Smith, Radosław Lach, Anne Babbage, Anne Y. Warren, Thomas J. Mitchell, Grant D. Stewart, Roland F. Schwarz, Charles Massie	0
2	K-Means Clustering of Hyperpolarised 13C-MRI Identifies Intratumoral Perfusion/Metabolism Mismatch in Renal Cell Carcinoma as the Best Predictor of the Highest Grade 2025 ·Cancers ·(unknown), (unknown), Mary A. McLean, João Duarte, Eva Serrão, Stephan Ursprung, Joshua Kaggie, Andrew B. Gill, Andrew N. Priest, Mireia Crispin‐Ortuzar, Anne Y. Warren, Sarah J. Welsh, Thomas J. Mitchell, Grant D. Stewart, Ferdia A. Gallagher	1
3	High-resolution and highly accelerated MRI T2 mapping as a tool to characterise renal tumour subtypes and grades 2024 ·European Radiology Experimental ·(unknown), (unknown), Andrew N. Priest, (unknown), Andrew B. Gill, Iosif Mendichovszky, Susan Francis, Anne Y. Warren, Brent O’Carrigan, Sarah J. Welsh, James O. Jones, Antony C. P. Riddick, James N. Armitage, Thomas J. Mitchell, Grant D. Stewart, Ferdia A. Gallagher	1
4	Multifocal, multiphenotypic tumours arising from an MTOR mutation acquired in early embryogenesis 2024 ·Oncogene ·(unknown), Madhanagopal Anandapadamanaban, Kevin W. Loudon, (unknown), Olga Perišić, Ruoyan Li, Matthew H V Byrne, Laura Allen, Kirsty Roberts, Yvette Hooks, Anne Y. Warren, Grant D. Stewart, Menna R. Clatworthy, Sarah A. Teichmann, Sam Behjati, Peter J. Campbell, Roger Williams, Thomas J. Mitchell	3
5	Multiarm, non-randomised, single-centre feasibility study—investigation of the differential biology between benign and malignant renal masses using advanced magnetic resonance imaging techniques (IBM-Renal): protocol 2024 ·BMJ Open ·(unknown), Mary A. McLean, (unknown), Marta Wylot, Joshua Kaggie, (unknown), Andrew B. Gill, João Duarte, M. Locke, Iosif Mendichovszky, (unknown), Andrew N. Priest, Anne Y. Warren, Sarah J. Welsh, James O. Jones, James N. Armitage, Thomas J. Mitchell, Grant D. Stewart, Ferdia A. Gallagher	2
6	‘Case of the Month’ from Addenbrooke's Hospital, Cambridge, UK : surgery after near complete response to combined immunotherapy and tyrosine kinase inhibitor therapy for metastatic renal cell carcinoma with inferior vena cava tumour thrombus 2024 ·British Journal of Urology ·James P. Blackmur, James N. Armitage, James O. Jones, Antony C. P. Riddick, Thomas J. Mitchell, Will Ince, (unknown), Anne Y. Warren, Kate Fife, Brent O’Carrigan, Grant D. Stewart	0
7	Clinical Implications of Basic Research: Exploring the Transformative Potential of Spatial 'Omics in Uro-oncology 2024 ·European Urology ·(unknown), Anthony S. Bates, David A. Braun, Renu Eapen, Markus Eckstein, Brandon J. Manley, Matthew I. Milowsky, Thomas J. Mitchell, Richard J. Bryant, John P. Sfakianos, Alastair Lamb	5
8	De novo detection of somatic mutations in high-throughput single-cell profiling data sets 2023 ·Nature Biotechnology ·Francesc Muyas, Carolin M. Sauer, Jose Espejo Valle-Inclán, Ruoyan Li, Raheleh Rahbari, Thomas J. Mitchell, Sahand Hormoz, Isidro Cortés‐Ciriano	43
9	Accurate detection of benign and malignant renal tumor subtypes with MethylBoostER: An epigenetic marker–driven learning framework 2022 ·Science Advances ·Sabrina H. Rossi, (unknown), (unknown), Kevin Brennan, Gahee Park, Christopher G. Smith, Radosław Lach, Thomas J. Mitchell, (unknown), Anne Babbage, Anne Y. Warren, John T. Leppert, Grant D. Stewart, Olivier Gevaert, Charles Massie, Shamith Samarajiwa	7
10	O07 Results of the first national audit of PBC management reveal significant variation in care delivery across the UK 2022 ·Abstracts ·Rachel J. Smith, Nadir Abbas, Steve Flack, Andrew D. Yeoman, Douglas Thorburn, Richard Aspinall, Rebecca L. Jones, Joanna Leithead, (unknown), Michael A. Heneghan, Collette Thain, Thomas J. Mitchell, Robert Mitchell-Thain, David Jones, Palak Trivedi, George Mells, Laith Alrubaiy	0
11	P13 Patient experience of primary biliary cholangitis (PBC) symptom evaluation and management in clinical appointments and pathways compared to The British Society of Gastroenterology (BSG)/UK-PBC PBC treatment and management guidelines: Results from PBC Foundation mobile app patient survey 2022 ·Abstracts ·Thomas J. Mitchell, (unknown), James Neuberger, Robert Mitchell-Thain	2
12	Extensive phylogenies of human development inferred from somatic mutations 2021 ·Nature ·Tim Coorens, Luiza Moore, Philip S. Robinson, Rashesh Sanghvi, Joseph Christopher, James Hewinson, Moritz J. Przybilla, Andrew Lawson, Michael Spencer Chapman, Alex Cagan, Thomas R. W. Oliver, Matthew D. C. Neville, Yvette Hooks, Ayesha Noorani, Thomas J. Mitchell, Rebecca C. Fitzgerald, Peter J. Campbell, Iñigo Martincorena, Raheleh Rahbari, Michael R. Stratton	75
13	Noncanonical IL6 Signaling-Mediated Activation of YAP Regulates Cell Migration and Invasion in Ovarian Clear Cell Cancer 2020 ·Cancer Research ·Walid J. Azar, Elizabeth L. Christie, Thomas J. Mitchell, David S. Liu, George Au‐Yeung, David D.L. Bowtell	14
14	Mechanisms generating cancer genome complexity from a single cell division error breakdown → 2020 ·Science ·Neil T. Umbreit, Cheng‐Zhong Zhang, (unknown), (unknown), Anna Cheng, Richard W. Tourdot, Lili Sun, Hannah F. Almubarak, Kim Judge, Thomas J. Mitchell, Alexander Spektor, David Pellman	276
15	Pilot study of head conformation changes over time in the Cavalier King Charles spaniel breed 2019 ·Veterinary Record ·Susan P. Knowler, (unknown), Thomas J. Mitchell, (unknown), Holger A. Volk, Clare Rusbridge	4
16	Selective Targeting of Cyclin E1-Amplified High-Grade Serous Ovarian Cancer by Cyclin-Dependent Kinase 2 and AKT Inhibition 2016 ·Clinical Cancer Research ·George Au‐Yeung, (unknown), Walid J. Azar, Thomas J. Mitchell, Kate E. Jarman, Kurt Lackovic, (unknown), Carleen Cullinane, Richard B. Pearson, Linda Mileshkin, Danny Rischin, Alison M. Karst, Ronny Drapkin, Dariush Etemadmoghadam, David D.L. Bowtell	100
17	Simple synchronisation for open sound control 2015 ·UWE Research Repository (UWE Bristol) ·Sebastian Madgwick, Thomas J. Mitchell, (unknown), Adrian Freed	2
18	Resistance to CDK2 Inhibitors Is Associated with Selection of Polyploid Cells in CCNE1 -Amplified Ovarian Cancer 2013 ·Clinical Cancer Research ·Dariush Etemadmoghadam, George Au‐Yeung, Meaghan Wall, Thomas J. Mitchell, Maya Kansara, Elizabeth Loehrer, (unknown), Joshy George, Sarah Ftouni, Barbara A. Weir, Scott L. Carter, Irma Gresshoff, Linda Mileshkin, Danny Rischin, William C. Hahn, Paul Waring, Gad Getz, Carleen Cullinane, Lynda J. Campbell, David D.L. Bowtell	90
19	Frequency Modulation Tone Matching Using a Fuzzy Clustering Evolution Strategy 2005 ·Journal of the Audio Engineering Society ·Thomas J. Mitchell	6
20	Who Is Drinking Nitrate in Their Well Water 1996 ·Journal of environmental health ·Thomas J. Mitchell, Anna K. Harding	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact